UHM Vacation IPO Final Day: GMP ₹26 (+₹26)
Well folks, it’s Day 5 of the UHM Vacation SME IPO on the BSE, and it’s the closing bell today! The IPO period, which kicked off on June 4th, wraps up on June 8th. We’ve seen the issue price set at ₹157 per share, with a lot size of 800 shares. The big question on everyone’s mind is how the subscription numbers have panned out on this crucial final day. Let’s dive into the latest updates and see what it all means for potential investors.
| Date | GMP | Est. Listing |
|---|---|---|
| 09 Jun | ₹0 | ₹157 |
| 08 Jun | +₹25 | ₹182 |
| 06 Jun | +₹28 | ₹185 |
| 05 Jun | +₹26 | ₹183 |
| 04 Jun | ₹0 | ₹157 |
Subscription Status
As of the latest update, the subscription figures for UHM Vacation’s IPO are showing 0x across the board – Retail, NII (Non-Institutional Investors), and QIB (Qualified Institutional Buyers). This is certainly an interesting situation on the closing day. Typically, you’d expect to see some movement, especially from retail investors, as the deadline looms. The complete lack of subscription across all categories, even on the final day, is quite unusual. It could indicate a few things. Perhaps investors are waiting for last-minute filings, or maybe the market sentiment isn’t leaning towards this particular SME offering. For NII and QIB, a 0x subscription is a strong signal that these sophisticated investors haven’t shown significant interest, which can be a red flag for others.
The retail segment also showing 0x is particularly noteworthy. Retail investors are often the driving force in SME IPOs, especially when the price is attractive. Their absence here might suggest a lack of awareness or a perception of higher risk associated with UHM Vacation. We’ll need to see if there’s any last-minute surge, but as it stands, the subscription is flat. This could concern investors looking for strong demand as an indicator of future performance.
| Category | Subscription | Progress |
|---|---|---|
| Retail | 3.86x | |
| NII / HNI | 0.97x | |
| QIB | 0.02x | |
| Total | 2.42x |
| Date | Retail | NII | QIB | Total |
|---|---|---|---|---|
| 08 Jun | 3.86x | 0.97x | 0.02x | 2.42x |
| 05 Jun | 0.93x | 0.47x | 0.02x | 0.71x |
| 04 Jun | 0.17x | 0.29x | 0.00x | 0.23x |
GMP Update
Now, let’s talk about the Grey Market Premium (GMP). This is where things get a bit more intriguing. Yesterday, the GMP for UHM Vacation was at ₹0. However, today, it has jumped to ₹26! That’s a significant leap from zero. A positive GMP indicates that investors are willing to pay a premium over the issue price in the grey market. An increase from ₹0 to ₹26 is encouraging, suggesting a potential upside on listing day. If this GMP holds, the expected listing price would be around ₹183 (Issue Price ₹157 + GMP ₹26). This ₹183 per share suggests a decent gain of approximately 16.57% over the issue price, which is always a welcome sight.
This jump in GMP, despite the lacklustre subscription numbers, presents a bit of a dichotomy. It’s possible that a segment of the market is more focused on the potential listing gains driven by the GMP, perhaps overlooking the subscription data. Or, it could be that the GMP is based on limited trades and might not be fully indicative of broader market sentiment. That said, a positive and increasing GMP is generally a good sign for listing performance.
Should You Apply?
So, the million-dollar question: should you still consider applying for UHM Vacation’s IPO on its closing day? It’s a bit of a mixed bag. On one hand, the subscription figures are alarmingly low, which usually points to a lack of investor confidence or demand. This can sometimes translate to a flat or even negative listing. However, the GMP has seen a remarkable surge to ₹26, suggesting a potential listing gain of around 16.57%.
This presents a classic dilemma. Do you trust the market’s demand as reflected in subscriptions, or the speculative pricing in the grey market? As per SEBI advisories, investors should always conduct their own due diligence. While the GMP is an indicator, it’s not a guarantee. The lack of subscription is a significant point to consider. If you’re a risk-averse investor, the low subscription numbers might be a reason to stay away. If you’re more inclined to chase potential listing gains and are comfortable with the associated risks, the positive GMP might entice you. The bottom line is, weigh the potential upside from the GMP against the downside indicated by the subscription data. Make your decision wisely.